Both in Biotechnology
CG Oncology vs Krystal Biotech
Over the past year CGON returned +73.3% and KRYS returned +52.9%; their daily moves had a correlation of 0.38.
CGON +73.3% KRYS +52.9%Growth of $1, one year, split-adjusted
| Metric | CGON | KRYS |
|---|---|---|
| Price | $67.71 | $310.84 |
| Market cap | $6.00B | $9.20B |
| Today | +5.70% | +1.90% |
| 1 month | +6.4% | −4.9% |
| 6 months | −0.4% | +7.6% |
| Year to date | +63.1% | +26.1% |
| 1 year | +61.6% | +57.1% |
| Revenue growth (YoY) | — | +30.2% |
| Gross margin | −239.2% | 94.1% |
| Net margin | −6832.8% | 49.5% |
| P/E (TTM) | — | 40.9× |
| Price / sales | 963.7× | 19.6× |
| Net cash | $1.03B | $911.9M |
| Dividend yield | — | — |
| Volatility (60d) | 43.2% | 39.1% |
| Short % of float | 12.9% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).